Test ID BLOD0127 Insulin Antibodies, Serum
Useful For
Predicting the future development of type 1 diabetes in asymptomatic children, adolescents, and young adults, when used in conjunction with family history, human leukocyte antigen-typing, and other autoantibodies, including glutamic acid decarboxylase (GAD65) and islet cell antigen 2 (IA-2) antibodies
Differential diagnosis of type 1 versus type 2 diabetes
Evaluating diabetics with insulin resistance in patients with established diabetes (type 1 or type 2)
Investigation of hypoglycemia in nondiabetic subjects
Specimen Type
SerumSpecimen Required
Supplies: Sarstedt Aliquot Tube, 5 mL (T914)
Collection Container/Tube:
Preferred: Red top
Acceptable: Serum gel
Submission Container/Tube: Plastic vial
Specimen Volume: 1.5 mL
Collection Instructions: Centrifuge and aliquot serum into a plastic vial.
Reject Due To
Gross hemolysis | Reject |
Gross lipemia | Reject |
Gross icterus | Reject |
Specimen Minimum Volume
1 mL
Specimen Stability Information
Specimen Type | Temperature | Time | Special Container |
---|---|---|---|
Serum | Refrigerated (preferred) | 28 days | |
Frozen | 28 days | ||
Ambient | 72 hours |
Day(s) Performed
Sunday, Wednesday
Report Available
3 to 9 daysMethod Name
Radioimmunoassay (RIA)
Performing Laboratory
Mayo Clinic Laboratories in RochesterCPT Code Information
86337
Reporting Name
Insulin Abs, SReference Values
≤0.02 nmol/L
Reference values apply to all ages.
Test Classification
This test was developed and its performance characteristics determined by Mayo Clinic in a manner consistent with CLIA requirements. It has not been cleared or approved by the US Food and Drug Administration.Secondary ID
8666SANFORD LABORATORY INTERFACE BUILD INFORMATION
Result Code | Result Code Description |
---|---|
13064 | Insulin Abs, S |